News
David Larsen, BTIG: Questioned the company’s collaborations with Lilly and Novo. CEO Schreiber explained that these partnerships enable seamless access for patients to branded therapies without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback